The Valley Desk

NCT06239480 · Interventional trial

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

Overall registry status Active not recruiting

Phase 3

Conditions Microcystic Lymphatic Malformation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov